Current position

Ray Dalio’s Viatris Inc (VTRS) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2021Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares2.29MHighest verified quarter-end share count
Quarters reported22Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Viatris Inc in Q1 2021. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 1.70M shares. The latest verified filing showed: Bought 134.0% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 134.0% more+972.46K shares · 1.70M shares reported after the change
Filing context

Quarter-end price $15.88 · Estimated holding basis $13.53

Q1 2026
Sold 49.1% of the position−698.93K shares · 725.88K shares remained
Filing context

Quarter-end price $13.51 · Estimated holding basis $10.38

Q4 2025
Sold 5.8% of the position−87.24K shares · 1.42M shares remained
Filing context

Quarter-end price $12.45 · Estimated holding basis $10.38

Q3 2025
Bought 342.9% more+1.17M shares · 1.51M shares reported after the change
Filing context

Quarter-end price $9.90 · Estimated holding basis $10.38

Q2 2025
Sold 44.1% of the position−269.45K shares · 341.42K shares remained
Filing context

Quarter-end price $8.93 · Estimated holding basis $12.01

Q1 2025
Sold 73.4% of the position−1.68M shares · 610.87K shares remained
Filing context

Quarter-end price $8.71 · Estimated holding basis $12.01

Portfolio importance

How important is Viatris Inc in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q2 2026
Current rank#154of 997 reported positions
Peak portfolio weight0.1%Q4 2024
Best historical rank#126Q4 2024
At peak importanceQ4 2024
VTRS
0.1%
Largest holding
22.1%
Cross-investor discovery

Who else owns Viatris Inc?

Also reported by 2 other tracked investors in their latest verified filings.

David EinhornDME Capital Management
VTRS1.1% of reported portfolio
Joel GreenblattGotham Asset Management
VTRS0.2% of reported portfolio
Explore Viatris Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$16.512026-09-11

Market context only; not an investor transaction price.

Latest filing quarter-end price$15.88Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$13.53Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.